<DOC>
	<DOC>NCT02725008</DOC>
	<brief_summary>Comparing one versus two doses of oral dexamethasone for the treatment of asthma in the pediatric emergency department.</brief_summary>
	<brief_title>Trial of One Versus Two Doses of Dexamethasone for Pediatric Asthma Exacerbation</brief_title>
	<detailed_description>A randomized double blinded placebo controlled trial comparing one dose of dexamethasone administered in the Emergency Department with two doses, the first given in the emergency department and the second 24 hours after the index ED visit.</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>History of asthma defined as at least two (2) prior episodes of respiratory illness characterized by wheezing treated with inhaled beta agonists pregnancy severe chronic cardiac, respiratory, neurological or neuromuscular disease complete resolution of symptoms after one treatment of beta agonists severe asthma symptoms as defined by a Pulmonary Index Score of 12 or greater</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Emergency Department</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>Steroid</keyword>
</DOC>